arrow
D

Dan Theodorescu

cedars-sinai medical center
H指数:85
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A National Institute on Aging workshop on sex differences in health across the lifespan

美国国立衰老研究所关于全生命周期健康性别差异的工作会议

2026-08-130
PRE
ZFP148 is a transcriptional repressor of cytolytic effector CD8+ T cell differentiation

ZFP148是细胞溶解效应CD8 T细胞分化的转录阻遏物

2026-03-270
OAAI
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome

陈, X.; 沈Y.; Choi, S.; Abdel-Hafiz, H.A.; Basu, M.; Hoelzen, L.; Tufano, M.; Kailasam Mani, S.K.; Ranjpour, M.; Zhu, J.; 等. 癌症和T细胞中Y染色体的同时丢失影响结局。Nature 2025, 642, 1041–1050. [Google Scholar] [CrossRef]

Nature
IF48.5
2025-06-040
OAAI
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
2024-10-011
PRE
NPEPPS Is a Druggable Driver of Platinum Resistance
2024-03-272
OAAI
The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

分子孪生人工智能平台整合多组学数据以预测胰腺癌患者的预后

2024-01-2216
OAAI
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
2023-12-194
OA
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners

在睾丸,前列腺,肾脏和 (腔型) 膀胱癌中使用nk-car免疫疗法靶向CD24,并鉴定直接的CD24相互作用伴侣

2023-06-265
OA